Portal de Periódicos da CAPES

Endovascular Treatment for Infrarenal Aortic Occlusion: A Systematic Review and Meta-Analysis

2019; Elsevier BV; Volume: 62; Linguagem: Inglês

10.1016/j.avsg.2019.05.034

1615-5947

Lijing Fang, Zhichao Lai, Chenyang Qiu, Jiang Shao, Yù Chen, Xiu Liu, Peng Yu, Bao Liu,

Cerebrovascular and Carotid Artery Diseases

BackgroundThis study aimed to synthesize data from recently published literature to evaluate the safety and efficacy of endovascular treatment (EVT) for infrarenal aortic occlusion (IAO).MethodsThe PubMed and Embase were searched to identify all studies reporting EVT for IAO from January 1st, 2000 to December 31st, 2017. Information about patients' characteristics, comorbidities, technical success, mortality, complications, and patency was collected and analyzed.Results9 articles consisting of 220 patients were included in this meta-analysis. Patients often had severe symptoms and many comorbidities. The overall technical success and periprocedural mortality was 95.64% (95% confidence interval [CI], 88.60%–99.42%) and 0.35% (95% CI, 0.00% to 2.33%). In successful cases, ankle-brachial index was raised from 0.42 to 0.91. The complication described in one article is of the whole samples and that of the technical success cases was not represented separately. We made the meta-analysis on the other 8 articles. Periprocedural complications included vascular complications (11.35% [95% CI: 3.50%–19.20%]) mainly pseudoaneurysm, thromboses, hematoma, and dissections; limb complications 8.28% (95% CI: 4.86%–13.77%); and renal complications 1.25% (95% CI: 0.00%–3.65%). In an article, vascular complications of whole samples were 12.24%, limb complication 6.12%, and renal complication 10.20%. Overall primary patency was 93.53% (95% CI: 89.37%–97.68%) at 1 year, 78.96% (95% CI: 72.26%–84.96%) at 3 years, and 75.31% (95% CI: 66.42%–84.20%) at 5 years. Overall secondary patency was 98.25% (95% CI: 95.50%–99.73%) at 1 year, 95.92% (95% CI: 89.25%–99.47%) at 3 years, and 94.02% (95% CI: 88.10%–98.00%) at 5 years.ConclusionsEVT for IAO is acceptable with relatively high technical success rate, low mortality, and satisfying short-term patency. Although primary patency was lower than after surgery, secondary patency was roughly similar to that of surgical repair. However, this conclusion is based on retrospective observational studies, and the results could be imprecise due to the limited sample sizes, especially in midterm and long-term patency. More studies with longer follow-up and bigger sample size are needed to further elucidate this. This study aimed to synthesize data from recently published literature to evaluate the safety and efficacy of endovascular treatment (EVT) for infrarenal aortic occlusion (IAO). The PubMed and Embase were searched to identify all studies reporting EVT for IAO from January 1st, 2000 to December 31st, 2017. Information about patients' characteristics, comorbidities, technical success, mortality, complications, and patency was collected and analyzed. 9 articles consisting of 220 patients were included in this meta-analysis. Patients often had severe symptoms and many comorbidities. The overall technical success and periprocedural mortality was 95.64% (95% confidence interval [CI], 88.60%–99.42%) and 0.35% (95% CI, 0.00% to 2.33%). In successful cases, ankle-brachial index was raised from 0.42 to 0.91. The complication described in one article is of the whole samples and that of the technical success cases was not represented separately. We made the meta-analysis on the other 8 articles. Periprocedural complications included vascular complications (11.35% [95% CI: 3.50%–19.20%]) mainly pseudoaneurysm, thromboses, hematoma, and dissections; limb complications 8.28% (95% CI: 4.86%–13.77%); and renal complications 1.25% (95% CI: 0.00%–3.65%). In an article, vascular complications of whole samples were 12.24%, limb complication 6.12%, and renal complication 10.20%. Overall primary patency was 93.53% (95% CI: 89.37%–97.68%) at 1 year, 78.96% (95% CI: 72.26%–84.96%) at 3 years, and 75.31% (95% CI: 66.42%–84.20%) at 5 years. Overall secondary patency was 98.25% (95% CI: 95.50%–99.73%) at 1 year, 95.92% (95% CI: 89.25%–99.47%) at 3 years, and 94.02% (95% CI: 88.10%–98.00%) at 5 years. EVT for IAO is acceptable with relatively high technical success rate, low mortality, and satisfying short-term patency. Although primary patency was lower than after surgery, secondary patency was roughly similar to that of surgical repair. However, this conclusion is based on retrospective observational studies, and the results could be imprecise due to the limited sample sizes, especially in midterm and long-term patency. More studies with longer follow-up and bigger sample size are needed to further elucidate this.